0001790599-20-000001.txt : 20200805 0001790599-20-000001.hdr.sgml : 20200805 20200805114631 ACCESSION NUMBER: 0001790599-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200805 DATE AS OF CHANGE: 20200805 EFFECTIVENESS DATE: 20200805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Variant Bio, Inc. CENTRAL INDEX KEY: 0001790599 IRS NUMBER: 832029303 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-372541 FILM NUMBER: 201076328 BUSINESS ADDRESS: STREET 1: 920 BROADWAY, 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 650-270-6137 MAIL ADDRESS: STREET 1: 920 BROADWAY, 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 D 1 primary_doc.xml X0708 D LIVE 0001790599 Variant Bio, Inc. 920 BROADWAY, 11TH FLOOR NEW YORK NY NEW YORK 10010 206-719-6382 DELAWARE Syngular, Inc. None Corporation true 2018 Andrew Farnum c/o Variant Bio, Inc. 920 Broadway, 11th Floor New York NY NEW YORK 10010 Executive Officer Director Kaja Wasik c/o Variant Bio, Inc. 920 Broadway, 11th Floor New York NY NEW YORK 10010 Executive Officer Director Josh Wolfe c/o Variant Bio, Inc. 920 Broadway, 11th Floor New York NY NEW YORK 10010 Director Bob More c/o Variant Bio, Inc. 920 Broadway, 11th Floor New York NY NEW YORK 10010 Director Julie Sunderland c/o Variant Bio, Inc. 920 Broadway, 11th Floor New York NY NEW YORK 10010 Director Biotechnology Decline to Disclose 06b false 2020-07-28 false true false 0 6699999 6099988 600011 false 6 0 0 0 false Variant Bio, Inc. /s/ Andrew Farnum Andrew Farnum Chief Executive Officer 2020-08-05